Timentin
- CAS No.
- 86482-18-0
- Chemical Name:
- Timentin
- Synonyms
- Temetine;TIMENTIN;TIMENTIN;TIMENTIN;TIMENTIN;ticarcillin-clavulanic acid;(2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid:(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- CBNumber:
- CB91381965
- Molecular Formula:
- C15H16N2O6S2.C8H9NO5
- Molecular Weight:
- 583.593
- MDL Number:
- MFCD01710900
- MOL File:
- 86482-18-0.mol
- MSDS File:
- SDS
Timentin Chemical Properties,Uses,Production
Antimicrobial activity
Activity is that of ticarcillin , the role of the inhibitor being to restore the activity against β-lactamase-producing strains that would otherwise hydrolyze the drug.
Pharmacokinetics
Cmax 3 g ticarcillin + 100 mg: 330 mg/L end: 8 mg/L end
clavulanate intravenous: infusion:
infusion
infusion (30 min)
Plasma half-life: 1.1 h 1.1 h
Plasma protein binding: 45% 25%
The pharmacokinetics of the two agents are mutually
unaffected
by co-administration. Ticarcillin can be detected
in tissues and interstitial fluid following parenteral administration.
Penetration into bile, peritoneal fluid and pleural fluid
has been demonstrated. Concentrations in blister fluid were
significantly lower than those in serum.
Around 60–70% of ticarcillin and 35–45% of clavulanic
acid are excreted unchanged in urine during the first 6 h after
administration of a single dose of the mixture.
Clinical Use
Septicemia, including bacteremia
Lower respiratory infections
Bone and joint infections
Skin and skin structure infections
Urinary tract infections (complicated and uncomplicated)
Gynecological infections, endometritis
Intra-abdominal infections, peritonitis
Its main use is in infections in which Ps. aeruginosa is suspected
or proven.
Side effects
Adverse reactions associated with ticarcillin occur . As with co-amoxiclav, there is a risk of cholestatic jaundice . Pseudomembranous colitis has been reported.
Timentin Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Career Henan Chemica Co | +86-0371-86658258 15093356674; | laboratory@coreychem.com | China | 30255 | 58 |
| Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 | product@acmec-e.com | China | 33349 | 58 |
| AILY INTL CHEMICAL CORP LTD | 025-83208295 18913388297 | China | 132 | 50 | |
| Adamas Reagent, Ltd. | 400-6009262 16621234537 | zhangsn@titansci.com | China | 14113 | 59 |
| Shanghai Macklin Biochemical Co.,Ltd. | 15221275939 15221275939 | shenlinxing@macklin.cn | China | 15878 | 55 |
| Chizhou Kailong Import and Export Trade Co., Ltd. | xg01_gj@163.com | China | 9503 | 50 | |
| Hubei widely chemical technology Co., Ltd. | 027-59402396 13419635609 | 13419635609@163.com | China | 1993 | 55 |
| Anhui kuer Bioengineering Co., Ltd | 0551-65171243 13810511747 | kuer@kuerhuaxue.com | China | 2997 | 55 |
| Hubei widely chemical technology Co., Ltd. | 027-83778895 18602735115 | 18602735115@163.com | China | 1991 | 64 |
| Hefei Bomei Biotechnology Co., Ltd. | 13739298932 | 531626407@qq.com | China | 3000 | 58 |
Related articles
- Ticarcillin–Clavulanic Acid: Clinical Uses and Toxicity
- Since its introduction for clinical use, ticarcillin–clavulanate has been used for a variety of clinical infections because of....
- Mar 21，2022
- Ticarcillin–Clavulanic Acid: Antimicrobial Activity, Susceptibility, Administration and Dosage etc.
- Ticarcillin–clavulanate is an injectable antibacterial combination consisting of two agents, a beta-lactam antibiotic (ticarci....
- Mar 21，2022